Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.
Marco SalvettiSibyl WrayGereon NellesNicholas BelvisoAchint KumarThijs KosterWanda Castro-BorreroMegan Vignosnull nullPublished in: Multiple sclerosis journal - experimental, translational and clinical (2024)
Peginterferon beta-1a is an effective therapy for managing relapsing multiple sclerosis. The identification of predictors of discontinuation can help inform strategies to enhance treatment persistence.